Journal
HUMAN IMMUNOLOGY
Volume 71, Issue 5, Pages 512-514Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.humimm.2010.02.003
Keywords
MICA gene polymorphism; NKG2D receptor; Inflammatory bowel disease; Crohn's disease; Ulcerative colitis
Categories
Funding
- Foundation Seneca of the Murcia Region [05748/PI/07]
- CIBERehd
- Institute de Salud Carlos III, Spain
Ask authors/readers for more resources
MICA is located at 46 kb centromeric of HLA-B, is highly polymorphic and interactions with NKG2D, its receptor on the surface of NK, T gamma delta, and T CD8 lymphocytes. A variation at amino acid position 129 of the alpha 2-heavy chain domain seems to categorize MICA alleles into strong and weak binder of NKG2D receptor, and thereby to influence effector cell function. Our aim was to study allele polymorphism of MICA and the functionally relevant dimorphism (129val/met) of MICA gene in inflammatory bowel disease (IBD) patients in our population. DNA was obtained from IBD patients (n = 88) and unrelated healthy Murcians (n = 154) and used to MICA genotyping using polymerase chain reaction-sequence-specific oligonucleotides. We did not find statistical differences in the distribution of MICA alleles between the IBD and control groups. However, we found a higher frequency of MICA-129met/met and a lower frequency of MICA-129val/met genotypes in IBD patients (mainly in ulcerative colitis) than in controls (pc = 0.02). These preliminary data could suggest a relevant role of MICA-129-val/met SNP (weak/strong binders of NKG2D receptor) in the pathogenesis of IBD. (C) 2010 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available